Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.

LaCasse, E C

Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation. [electronic resource] - Blood Oct 1999 - 2901-10 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0006-4971


Antibodies, Monoclonal--pharmacology
B-Lymphocytes--chemistry
Bacterial Toxins--pharmacology
Biomarkers
Biomarkers, Tumor
Blood Cells--chemistry
Bone Marrow Cells--chemistry
Bone Marrow Purging--methods
Breast Neoplasms--chemistry
Carcinoma--chemistry
Cell Separation--methods
Cells, Cultured
Colony-Forming Units Assay
Female
Flow Cytometry
Genes, Immunoglobulin
Glycolipids--analysis
Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cells--chemistry
Humans
Immunoglobulin Heavy Chains--genetics
Lymphoma, B-Cell--chemistry
Lymphoma, Follicular--chemistry
Male
Multiple Myeloma--metabolism
Neoplasm Proteins--analysis
Neoplastic Stem Cells--chemistry
Organ Specificity
Plasma Cells--chemistry
Receptors, Cell Surface--analysis
Reverse Transcriptase Polymerase Chain Reaction
Shiga Toxin 1
Transplantation, Autologous
Trihexosylceramides--analysis
Tumor Cells, Cultured
Tumor Stem Cell Assay